Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Economic burden of overactive bladder substantial in the US

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Economic burden of overactive bladder substantial in the US. Pharmacoecon. Outcomes News 423, 9 (2003). https://doi.org/10.1007/BF03276586

    Download citation

    Keywords

    • Productivity Loss
    • Overactive Bladder
    • Total Direct Cost
    • Bladder Evaluation
    • Institutional Cost